Back
Why MNTL ETF?
Unmet medical need
1 billion people worldwide suffer from CNS diseases. Many illnesses have limited disease modifying treatments and are a huge economic burden on healthcare systems.
Source: WHO
Innovation
An innovation wave is rising with the watershed launch of the first medicines for Alzheimer’s to breakthroughs in gene editing, non-opioid pain, and targeted treatments for depression.
Research expertise
The fund conducts deep and comprehensive research, in an effort to identify those companies that deliver breakthrough solutions at attractive valuations.
Growing Market
The outsized economic burden of these diseases means a large and fast-growing addressable market with high payer acceptance according to Tema’s research.
Uncorrelated
Performance of many companies relies on clinical or commercial success, which is an uncorrelated source of return.
Fund Overview
Fund Details
As of April 26, 2024
Fund Summary
The actively managed Tema Neuroscience and Mental Health ETF seeks to provide long-term growth of capital by investing in companies tackling diseases of the central nervous system and mental health. We have reached a watershed moment in innovation with the approval of the first disease modifying agent in Alzheimer’s with significant innovation following in neuropsychology and genetic neurological disorders. The complex combination of scientific, regulatory and financing risks requires investment and scientific expertise to navigate this secular theme.
Portfolio Manager
Investment Partner
David K. Song, MD, PhD, CFA
How does the Tema MNTL ETF fit in a portfolio?
Investment Style Box
Source: Tema. The investment style Box reveal’s a fund’s investment strategy by showing its investment style and market capitalization based on the fund’s portfolio holdings.
Potential Portfolio
Equity Allocation
3-5%
Equity Satellite
MNTL ETF
Equity core
Where could a position be funded from?
- Could be a more targeted alternative to existing healthcare or biopharma exposure in a portfolio.
- Provides a balanced exposure across key technologies and company risk profiles.
- Could replace a satellite position or a growth-oriented alpha driver.
How to buy
.svg){kind=small}
*Neither Tema Global Limited nor undefined ETF are affiliated with these financial services firms. Their listing should not be viewed as a recommendation or endorsement.